Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Construction in Progress (2018 - 2022)

Eton Pharmaceuticals' Construction in Progress history spans 4 years, with the latest figure at $12000.0 for Q4 2022.

  • On a quarterly basis, Construction in Progress changed N/A to $12000.0 in Q4 2022 year-over-year; TTM through Dec 2022 was $12000.0, a N/A change, with the full-year FY2022 number at $12000.0, changed N/A from a year prior.
  • Construction in Progress hit $12000.0 in Q4 2022 for Eton Pharmaceuticals, roughly flat from $12000.0 in the prior quarter.
  • Over the last five years, Construction in Progress for ETON hit a ceiling of $873000.0 in Q1 2019 and a floor of $1000.0 in Q3 2020.
  • Historically, Construction in Progress has averaged $175750.0 across 4 years, with a median of $10500.0 in 2019.
  • The widest YoY moves for Construction in Progress: up 66.67% in 2020, down 99.54% in 2020.
  • Tracing ETON's Construction in Progress over 4 years: stood at $492000.0 in 2018, then crashed by 98.17% to $9000.0 in 2019, then plummeted by 88.89% to $1000.0 in 2020, then surged by 1100.0% to $12000.0 in 2022.
  • Business Quant data shows Construction in Progress for ETON at $12000.0 in Q4 2022, $12000.0 in Q1 2022, and $1000.0 in Q3 2020.